Juno Therapeutics Signs $1 Billion Development Pact With Celgene By: Benzinga via Benzinga June 30, 2015 at 07:28 AM EDT Juno Therapeutics Inc (NASDAQ: JUNO) soared Monday afternoon on news that it signed a 10-year drug development pact with Celgene ... Read More >> Related Stocks: Celgene Corp